Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 22;3(2):100097.
doi: 10.1016/j.opresp.2021.100097. eCollection 2021 Apr-Jun.

[SEPAR Recommendations for COVID-19 Vaccination in Patients With Respiratory Diseases]

[Article in Spanish]
Affiliations

[SEPAR Recommendations for COVID-19 Vaccination in Patients With Respiratory Diseases]

[Article in Spanish]
Felipe Villar-Álvarez et al. Open Respir Arch. .

Abstract

The Spanish Society of Pneumonology and Thoracic Surgery (SEPAR) has elaborated this document of recommendations for COVID-19 vaccination in patients with respiratory diseases aimed to help healthcare personnel make decisions about how to act in case of COVID-19 vaccination in these patients.The recommendations have been developed by a group of experts in this field after reviewing the materials published up to March 7, 2021, the information provided by different scientific societies, drug agencies and the strategies of the governmental bodies up to this date.We can conclude that COVID-19 vaccines are not only safe and effective, but also prior in vulnerable patients with chronic respiratory diseases. In addition, an active involvement of healthcare professionals, who manage these diseases, in the vaccination strategy is the key to achieve good adherence and high vaccination coverage.

La Sociedad Española de Neumología y Cirugía Torácica (SEPAR) ha elaborado este documento de recomendaciones sobre la vacuna para la COVID-19 en las enfermedades respiratorias, con el objetivo de ayudar al personal sanitario en la toma de decisiones sobre cómo actuar en la vacunación de estos pacientes.

Las recomendaciones han sido elaboradas por un grupo de expertos en la materia, tras la revisión de la literatura recopilada hasta el 7 de marzo del 2021, y de la información aportada por distintas sociedades científicas, agencias del medicamento y estrategias de organismos gubernamentales hasta esa fecha.

Podemos concluir que las vacunas para la COVID-19 no solo son seguras y eficaces, sino que, en aquellos pacientes vulnerables con enfermedades respiratorias crónicas, son prioritarias. Además, la implicación activa de los profesionales sanitarios que manejan estas patologías en la estrategia de vacunación es clave para lograr una buena adherencia y coberturas vacunales elevadas.

Keywords: COVID-19; Recommendation; Respiratory; SARS-CoV-2; Vaccine.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Doherty M., Buchy P., Standaert B., Giaquinto C., Prado-Cohrs D. Vaccine impact: Benefits for human health. Vaccine. 2016;34:6707–6714. - PubMed
    1. Peña-Otero D., Díaz-Pérez D., De la Rosa-Carrillo D., Bello-Dronda S. Are we ready for the new coronavirus? Arch Bronconeumol. 2020;56:195–196. - PMC - PubMed
    1. WHO Draft landscape and tracker of COVID-19 candidate vaccines. 2021 https://www.who.int/publications/m/item/draft-landscape-of-covid-19-cand....
    1. Villar-Álvarez F., López-Yeste P., Lazo-Meneses P. Fases clínicas de la COVID-19. Diagnóstico diferencial. Rev Patol Respir. 2020;23:S256–S262.
    1. Cordovilla R., Álvarez S., Llanos L., Nuñez-Ares A., Cases-Viedma E., Díaz-Pérez D., et al. SEPAR and AEER consensus recommendations on the Use of Bronchoscopy and Airway Sampling in Patients with Suspected or Confirmed COVID-19 Infection. Arch Bronconeumol. 2020;56:19–26.

Publication types

LinkOut - more resources

-